Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.
British Journal of Haematology.
Times cited: 16
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
Times cited: 147